Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.
about
Characterization of recombinant and brain neuropsin, a plasticity-related serine proteaseProteolytic processing of the cilium adhesin MHJ_0194 (P123J ) in Mycoplasma hyopneumoniae generates a functionally diverse array of cleavage fragments that bind multiple host molecules.Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombinUrokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpressionRegulation of neuronal cells and astrocytes by protease nexin-1 and thrombin.Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.Plasminogen activators and plasminogen activator inhibitors in neural development.Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cellsRole of plasminogen activator in pemphigus vulgaris.Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin.92-kD type IV collagenase mediates invasion of human cytotrophoblasts.Cloning of a 72 kDa matrix metalloproteinase (gelatinase) from chicken embryo fibroblasts using gene family PCR: expression of the gelatinase increases upon malignant transformation.A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways.HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor.From the crest to the periphery: control of pigment cell migration and lineage segregation.Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effectModulation of proteolytic activity during neuritogenesis in the PC12 nerve cell: differential control of plasminogen activator and plasminogen activator inhibitor activities by nerve growth factor and dibutyryl-cyclic AMP.Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-beta 1.Human plasma fibronectin as a substrate for human urokinase.Influence of the angiotensin system on endothelial and smooth muscle cell migration.Pathogenesis of corneal epithelial defects: role of plasminogen activator.Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain.Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
P2860
Q28590880-B66595F6-486D-4C9D-AD71-9CD92BB557AAQ30668609-3EE51EE5-3EE0-44A1-BA7E-C4E9CFA1480AQ34256090-33185663-F301-4517-B6B5-05EFD816CDFCQ34489359-3109021A-BB6F-4E4D-B3E9-D2CBB55B1B6FQ35098346-8DC7CA48-022F-4D8B-BCBC-CB4689944EF3Q35186172-35E245A2-C916-45D2-98E3-C552BEA4651BQ35208646-B99C01F9-D072-4980-94E3-EF8351B803BCQ35224533-6F9C0A25-08CF-4C74-8F91-7CE4D032AD89Q35238060-DFEC8BC5-EFE3-4E06-A301-91234464B8FCQ35815953-517C061F-7B6C-4E19-8E8D-FAAFF12C9D40Q36072526-1543ACBA-0743-4EE3-A573-1A1C34408925Q36218449-14A49013-C66F-47AB-B4EE-41D5B54B2149Q36529534-33508731-F12B-4276-898E-5B25B933DA15Q36732007-9696683B-7216-4778-82E3-B8814599BF8CQ36772566-C4A73ECB-E252-41C4-AB62-589607543AD7Q37415725-13E3C352-5CE1-4147-85C2-CD5992995968Q40792801-1050C14E-F3FC-4E00-95A5-BF5F8CE52667Q40811857-41D3F0F8-4220-4275-A356-9801F859CAE4Q41064411-9A68BECA-272A-4F5A-980F-8A4E09F0180DQ41673525-3BACA220-AF14-4C5A-9953-829AFD460E00Q41919634-285502A3-B450-4A0A-8701-33D9819063D1Q42062715-B94D1780-49B7-4B8C-89A6-979B8CA36470Q42773815-4AA1C5CD-4490-4F79-BB46-C8D29C3CAB27Q44291002-A6275667-2EC0-4DED-803C-31854C0DB144Q46308799-3658D571-F0E7-4A12-96B3-49F8BF4B462BQ46797055-AF77BEE8-DEFC-4C19-A3D2-4926EE957B86Q48345667-D5AE87E6-AF57-41F9-BA84-B1F13C2F0C35Q53631087-5505D68E-AC82-49EE-9B6F-BA5A4DBEEF32
P2860
Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Limited cleavage of cellular f ...... rified from transformed cells.
@ast
Limited cleavage of cellular f ...... rified from transformed cells.
@en
Limited cleavage of cellular f ...... rified from transformed cells.
@nl
type
label
Limited cleavage of cellular f ...... rified from transformed cells.
@ast
Limited cleavage of cellular f ...... rified from transformed cells.
@en
Limited cleavage of cellular f ...... rified from transformed cells.
@nl
prefLabel
Limited cleavage of cellular f ...... rified from transformed cells.
@ast
Limited cleavage of cellular f ...... rified from transformed cells.
@en
Limited cleavage of cellular f ...... rified from transformed cells.
@nl
P2093
P2860
P356
P1476
Limited cleavage of cellular f ...... rified from transformed cells.
@en
P2093
J P Quigley
L M Sullivan
R Schwimmer
P2860
P304
P356
10.1073/PNAS.84.9.2776
P407
P577
1987-05-01T00:00:00Z